Although vimentin and N-cadherin losses were not associated with any rise in E-cadherin expression, a late marker of the MET process, it is worth noting that other characteristic features of BC cell differentiation (cell growth arrest, formation of intracellular lipid bodies, and β-casein production) were distinctly detected during D609 treatment. Here, VIM is linked to breast cancer.